All the mutation-dependent metabolic alterations described for ccRCC, pRCC and chRCC are beneficial for the growth and progression of these cancers but also trigger severe stress responses, in particular from the ER. The gene discussed is PRCC; the disease is nonpapillary renal cell carcinoma.